{
  "retracted": false,
  "timestamp": 1575590400000,
  "updates": [
    {
      "timestamp": 1591694898207,
      "identifier": {
        "doi": "10.36959/571/718"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.36959/571/718"
  },
  "journal": "Annals of Lung Cancer",
  "publisher": "sPage.direcT",
  "title": "Survival and Grades vs. Costs and Values of Nivolumab in Cancer; The Impact of PD-L1 Positivity"
}
